ESTANasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

ESTABLISHMENT LABS HOLDINGS INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$58.26−0.92 (-1.55%)

Close on Oct 19, 2026

Market cap: $1.75B
P/E (TTM): –
Dividend yield: –

ESTABLISHMENT LABS HOLDINGS INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31
Revenue	211	166	165	162	127	85	90	61	35
Cost of Revenue	65	57	58	55	41	32	35	25	17
Gross Profit	146	110	107	107	85	53	55	36	18
Research & Development	20	20	26	20	18	14	15	13	6.86
Selling, General & Admin	165	140	146	126	92	67	71	47	31
Operating Expenses	185	160	172	146	111	80	86	60	38
Operating Income	-39	-50	-65	-40	-25	-28	-31	-24	-20
Interest Expense	25	21	15	12	9.06	9.37	8.70	8.81	10
Interest & Investment Income	0.42	1.48	1.02	0.09	0.02	0.02	0.00	0.02	0.02
Other Non-Operating Income	5.82	-15	0.82	-3.18	-6.27	-2.68	-1.21	-2.39	-0.40
Asset Impairment Charges	0	0	0	0	0	0	0	0	0
Gain (Loss) on Sale of Assets	-0.15	-0.16	-0.28	-0.23	-0.17	-0.17	-0.07	-0.08	0
Pretax Income	-58	-85	-79	-73	-40	-38	-38	-21	-35
Income Tax Expense	-6.96	-0.03	-0.08	2.39	1.43	0.10	0.64	0.22	0.11
Net Income	-51	-85	-79	-75	-41	-38	-38	-21	-35
EPS (Basic)(per share)	-1.72	-3.00	-3.07	-3.08	-1.72	-1.63	-1.86	-1.22	-3.41
EPS (Diluted)(per share)	-1.72	-3.00	-3.07	-3.08	-1.72	-1.63	-1.86	-1.22	-3.41
Shares Outstanding (Basic, Weighted)(shares)	30	28	26	24	24	23	21	17	10
Shares Outstanding (Diluted, Weighted)(shares)	30	28	26	24	24	23	21	17	10
EBITDA	-33	-45	-62	-37	-23	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 70.5%
Operating margin: -7.6%
Net margin: -15.8%
Return on equity, FY2025: -133.3%

Financial strength

Current ratio: 3.84
Debt to equity: 12.11
Debt to assets: 74.4%
Cash to current liabilities: 110.2%

Valuation

P/E ratio: –
Price to sales: 7.14
Price to book: 81.22
Dividend yield: –